Position in EXEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$35,723,375
+$4,673,975 QoQ
Shares Held
656,559
-9.3% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#58
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. EXEL ranks #10 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,723,375 | 656,559 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $31,049,400 | 723,931 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $31,587,886 | 720,691 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $30,942,620 | 749,216 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $34,241,167 | 776,796 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $29,720,821 | 805,006 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $27,542,896 | 827,114 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $21,610,407 | 832,771 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $19,170,572 | 853,163 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $21,112,296 | 889,688 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $22,665,176 | 944,776 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $21,452,373 | 981,802 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $19,228,099 | 1,006,180 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $18,965,802 | 977,115 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $15,156,324 | 944,908 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,584,783 | 930,152 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $18,932,687 | 909,351 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $18,687,923 | 824,346 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $15,107,268 | 826,437 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $16,797,780 | 794,597 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $14,602,127 | 801,434 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $18,581,788 | 822,567 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $16,838,509 | 838,989 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $20,888,172 | 854,322 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $20,675,949 | 870,933 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $14,230,384 | 826,387 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||